Real-world analysis of the use of lenvatinib in differentiated thyroid cancers

Lenvatinib is one of the approved treatments for radioiodine-refractory differentiated thyroid cancers. However, there is very limited data from India on real-world efficacy and adverse events of Lenvatinib and hence this analysis was performed. This was a retrospective analysis in which patients of...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Ecancermedicalscience 2023, Vol.17, p.1500-1500
Hauptverfasser:	Peelay, Zoya, Parekh, Deevyashali, Patil, Vijay M, Noronha, Vanita, Menon, Nandini, Prabhash, Kumar
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer therapies Chemotherapy Compliance Oncology Patients Response rates Thyroid cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!